X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (159650) 159650
Patent (2340) 2340
Newspaper Article (1608) 1608
Newsletter (566) 566
Book Chapter (453) 453
Magazine Article (368) 368
Government Document (159) 159
Book / eBook (88) 88
Reference (59) 59
Conference Proceeding (54) 54
Streaming Video (44) 44
Dissertation (41) 41
Trade Publication Article (37) 37
Transcript (29) 29
Publication (20) 20
Web Resource (11) 11
Book Review (10) 10
Report (3) 3
Paper (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (88278) 88278
animals (78815) 78815
female (72884) 72884
humans (70596) 70596
body weight - drug effects (45781) 45781
rats (42880) 42880
body weight (40855) 40855
body mass index (31577) 31577
adult (31202) 31202
middle aged (28710) 28710
obesity (27799) 27799
mice (23031) 23031
endocrinology & metabolism (18188) 18188
aged (17799) 17799
risk factors (16928) 16928
research (15478) 15478
analysis (14495) 14495
diet (13747) 13747
pharmacology & pharmacy (13714) 13714
diabetes (13563) 13563
health aspects (13178) 13178
time factors (12930) 12930
metabolism (12633) 12633
adolescent (11947) 11947
dose-response relationship, drug (11598) 11598
research article (11537) 11537
organ size - drug effects (11482) 11482
medicine (11373) 11373
nutrition & dietetics (11269) 11269
physiological aspects (10895) 10895
pregnancy (10859) 10859
physiology (10578) 10578
studies (10130) 10130
rats, sprague-dawley (10065) 10065
insulin (9521) 9521
glucose (9456) 9456
rodents (9372) 9372
rats, wistar (9117) 9117
neurosciences (9085) 9085
toxicology (8958) 8958
insulin resistance (8570) 8570
multidisciplinary sciences (8558) 8558
care and treatment (8115) 8115
body-mass index (8038) 8038
young adult (8012) 8012
child (7836) 7836
mortality (7772) 7772
inflammation (7770) 7770
treatment outcome (7711) 7711
risk (7708) 7708
blood pressure (7695) 7695
proteins (7622) 7622
science (7589) 7589
hypertension (7521) 7521
liver - drug effects (7311) 7311
medicine & public health (7123) 7123
prevalence (7024) 7024
insulin-resistance (6764) 6764
blood glucose - metabolism (6747) 6747
children (6734) 6734
liver (6706) 6706
biochemistry & molecular biology (6683) 6683
oxidative stress (6611) 6611
age (6582) 6582
metabolic syndrome (6553) 6553
expression (6535) 6535
eating - drug effects (6521) 6521
oncology (6511) 6511
body composition (6470) 6470
disease models, animal (6469) 6469
nutrition (6358) 6358
diabetes mellitus (6277) 6277
exercise (6277) 6277
body-weight (6173) 6173
patients (6093) 6093
rats, inbred strains (6047) 6047
cholesterol (6014) 6014
cancer (6010) 6010
type 2 diabetes (5906) 5906
women (5902) 5902
mice, inbred c57bl (5900) 5900
disease (5879) 5879
liver - metabolism (5833) 5833
lipids (5777) 5777
surgery (5703) 5703
gene expression (5483) 5483
prospective studies (5414) 5414
medical research (5391) 5391
cross-sectional studies (5261) 5261
blood pressure - drug effects (5222) 5222
dietary supplements (5222) 5222
age factors (5217) 5217
weight loss (5131) 5131
psychiatry (5065) 5065
insulin - blood (5062) 5062
brain (5033) 5033
organ size (4962) 4962
pediatrics (4948) 4948
aged, 80 and over (4896) 4896
toxicity (4830) 4830
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (29) 29
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Online Resources - Online (5) 5
UofT at Mississauga - Stacks (4) 4
Media Commons - Microtexts (3) 3
UTL at Downsview - May be requested (3) 3
OISE - Theses (2) 2
Robarts - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Closed Orders (1) 1
Gerstein Science - Missing (1) 1
Law (Bora Laskin) - Theses (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (162341) 162341
Chinese (2010) 2010
Japanese (2010) 2010
German (1071) 1071
Russian (575) 575
French (543) 543
Portuguese (310) 310
Spanish (293) 293
Italian (218) 218
Polish (109) 109
Czech (58) 58
Norwegian (57) 57
Dutch (45) 45
Bulgarian (38) 38
Danish (35) 35
Hungarian (31) 31
Ukrainian (31) 31
Slovak (30) 30
Korean (28) 28
Swedish (26) 26
Turkish (23) 23
Arabic (9) 9
Serbian (7) 7
Romanian (5) 5
Croatian (4) 4
Finnish (4) 4
Indonesian (4) 4
Persian (4) 4
Hebrew (2) 2
Slovenian (2) 2
Corsican (1) 1
Latvian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9774, pp. 1341 - 1352
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 3, p. e0151511
...) related to obesity and insulin resistance. Currently, medical interventions for NAFLD have focused on diet control and exercise to reduce body weight, and there is a requirement for effective pharmacological therapies... 
ADIPOCYTE DEATH | HYPERGLYCEMIA | DAPAGLIFLOZIN | ELEMENT-BINDING PROTEIN-1 | INSULIN-RESISTANCE | GLUCOSE | MULTIDISCIPLINARY SCIENCES | DISEASE | DOUBLE-BLIND | COTRANSPORTER 2 INHIBITION | ADIPOSE-TISSUE | Epididymis - metabolism | Thiophenes - therapeutic use | Liver - pathology | Humans | Body Weight - drug effects | Diet, High-Fat - adverse effects | Non-alcoholic Fatty Liver Disease - etiology | Male | Hyperphagia - chemically induced | Adipose Tissue - metabolism | Liver - drug effects | Adult | Glucosides - therapeutic use | Drug Evaluation, Preclinical | Epididymis - drug effects | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Glucosides - pharmacology | Obesity - complications | Liver - metabolism | Mice, Inbred C57BL | Insulin Resistance | Thiophenes - pharmacology | Sodium-Glucose Transporter 2 Inhibitors | Energy Intake - drug effects | Hypoglycemic Agents - pharmacology | Non-alcoholic Fatty Liver Disease - drug therapy | Organ Size - drug effects | Animals | Weight Loss | Non-alcoholic Fatty Liver Disease - prevention & control | Glucose - metabolism | Mice, Obese | Mice | Lipids - analysis | Diabetes Mellitus, Type 2 - drug therapy | Leptin - deficiency | Adipose Tissue - drug effects | Type 2 diabetes | Complications and side effects | Fatty liver | Hypoglycemic agents | Dosage and administration | Drug therapy | Risk factors | Drugs | Adipose tissue | Body fat | Liver | Body weight | Homeostasis | Lipids | Adipocytes | Glucose | Proximal tubules | Accumulation | High fat diet | Liver cancer | Hyperglycemia | Rodents | Hyperphagia | Energy intake | Obesity | Excretion | Liver diseases | Kidneys | Research & development--R&D | Diabetes mellitus | Tubules | Reabsorption | Pharmacology | Metabolism | Insulin | Patients | Steatosis | Energy balance | Inhibitors | Sodium | Leptin | Weight reduction | Insulin resistance | Diabetes | Laboratory animals | Endocrinology | Kidney transplantation | Research & development | R&D
Journal Article
Journal Article
Diabetes (New York, N.Y.), ISSN 1939-327X, 2017, Volume 66, Issue 4, pp. 908 - 919
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e101702
Journal Article